Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
What is a passive retirement strategy emphasizes broad diversification, low fees, and long-term holding to minimize churn while maximizing compounding.
18,004 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Bank of America will keep funding housing affordability efforts, surpassing its initial goal and making the Community...
Gas prices are nudging shoppers toward membership clubs, with Costco delivering a strong quarterly performance. The t...
When a kulicke soffa director sold 20,000 shares for about $2 million, it prompts questions about insider intent and ...
SMCI's Q3 FY2026 revenue surged and guidance was raised, but investors are weighing whether the stock can reach $60 b...
Meta’s AI push has investors wondering if will meta stock $800 this year as results beat and capex climbs. The stock ...
AI stocks keep surprising investors with durable growth. Here’s a detailed, practical case for a single stock that ch...
Alaska Air Group stock surged this week as investors weighed fuel-cost pressures against resilient demand and discipl...
Investing in Micron today means evaluating AI-driven memory demand, pricing power, and the memory market cycle. This ...
As summer approaches, investors debate whether the market is primed for a rally or headed for a slump. This guide bre...
A CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
A growth stock down dip can open the door to meaningful long-term gains. Learn how to assess, plan, and act with conf...